CSF1R expression in soft tissue tumors

被引：0
|
作者：
West, RB
Kaygusuz, G
Subramanian, S
Corless, CL
Rubin, BP
Montgometry, K
Zhu, SX
Nielsen, TI
Patel, R
Goldblum, JR
Brown, PO
机构：
[1] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[2] Ankara Univ, Sch Med, TR-06100 Ankara, Turkey
[3] Oregon Hlth Sci Univ, Inst Canc, Portland, OR 97201 USA
[4] Univ Washington, Med Ctr, Seattle, WA 98195 USA
[5] Vancouver Gen Hosp, Vancouver, BC, Canada
[6] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[7] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
MODERN PATHOLOGY | 2005年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
89
引用
收藏
页码：23A / 23A
页数：1
相关论文
共 50 条
  • [31] CSF1R signaling is a regulator of pathogenesis in progressive MS
    Nellwyn Hagan
    John L. Kane
    Deepak Grover
    Lisa Woodworth
    Charlotte Madore
    Jacqueline Saleh
    Jose Sancho
    Jinyu Liu
    Yi Li
    Jonathan Proto
    Matija Zelic
    Amy Mahan
    Michael Kothe
    Andrew A. Scholte
    Maria Fitzgerald
    Barbara Gisevius
    Aiden Haghikia
    Oleg Butovsky
    Dimitry Ofengeim
    Cell Death & Disease, 11
  • [32] CSF1R signaling is a regulator of pathogenesis in progressive MS
    Hagan, Nellwyn
    Kane, John L.
    Grover, Deepak
    Woodworth, Lisa
    Madore, Charlotte
    Saleh, Jacqueline
    Sancho, Jose
    Liu, Jinyu
    Li, Yi
    Proto, Jonathan
    Zelic, Matija
    Mahan, Amy
    Kothe, Michael
    Scholte, Andrew A.
    Fitzgerald, Maria
    Gisevius, Barbara
    Haghikia, Aiden
    Butovsky, Oleg
    Ofengeim, Dimitry
    CELL DEATH & DISEASE, 2020, 11 (10)
  • [33] Targeting of CSF1R and PD1 in Experimental Glioma
    Przystal, Justyna M.
    Becker, Hannes
    Canjuga, Denis
    Ries, Carola H.
    Schtmittnaegel, Martina
    Korinetska, Nataliya
    Koch, Marilin
    Schittenhelm, Jens
    Tatagiba, Marcos
    Beck, Susanne C.
    Tabatabai, Ghazaleh
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 35 - 36
  • [34] TARGETING CSF1R AND PD1 IN EXPERIMENTAL GLIOMA
    Becker, Hannes
    Przystal, Justyna M.
    Canjuga, Denis
    Tsiami, Foteini
    Anderle, Nicole
    Keller, Anna-Lena
    Pohl, Anja
    Ries, Carola H.
    Schmittnaegel, Martina
    Korinetska, Nataliya
    Koch, Marilin
    Schittenhelm, Jens
    Tatagiba, Marcos
    Schmees, Christian
    Beck, Susanne C.
    Tabatabai, Ghazaleh
    NEURO-ONCOLOGY, 2021, 23 : 205 - 205
  • [35] EHD1 as a Positive Regulator of Macrophage CSF1R
    Cypher, Luke R.
    Bielecki, Timothy Alan
    Iseka, Fany M.
    Band, Vimla
    Band, Hamid
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [36] Myelopathy in a patient with leukodystrophy due to CSF1R mutation
    Ho, Victoria M.
    Hovsepian, Dominic A.
    Shieh, Perry B.
    NEUROLOGY-GENETICS, 2019, 5 (06)
  • [37] The potential mechanism of INHBC and CSF1R in diabetic nephropathy
    Du, X-Y
    Zheng, B-T
    Pang, Y.
    Zhang, W.
    Liu, M.
    Xu, X-L
    Zhou, S-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (04) : 1970 - 1978
  • [38] Challenges and prospects of CSF1R targeting for advanced malignancies
    Moeller, Ann
    Kurzrock, Razelle
    Botta, Gregory P.
    Adashek, Jacob J.
    Patel, Hitendra
    Lee, Suzanna
    Pabla, Sarabjot
    Nesline, Mary K.
    Conroy, Jeffrey
    Sicklick, Jason K.
    Kato, Shumei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (07): : 3257 - +
  • [39] Role of CSF1R Inhibitor Pexidartinib for the Treatment of Cancer
    Russian Journal of Bioorganic Chemistry, 2022, 48 : S1 - S8
  • [40] CSF1/CSF1R signaling mediates malignant pleural effusion formation
    Kosti, Chrysavgi N.
    Vaitsi, Photene C.
    Pappas, Apostolos G.
    Iliopoulou, Marianthi P.
    Psarra, Katherina K.
    Magkouta, Sophia F.
    Kalomenidis, Ioannis T.
    JCI INSIGHT, 2022, 7 (06)
12345